Chi Sheng Pharma & Biotech Co., Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 267.07 million compared to TWD 235.45 million a year ago. Revenue was TWD 267.07 million compared to TWD 235.45 million a year ago. Net income was TWD 22.28 million compared to TWD 8.22 million a year ago. Basic earnings per share from continuing operations was TWD 0.39 compared to TWD 0.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.39 compared to TWD 0.14 a year ago. For the nine months, sales was TWD 761.46 million compared to TWD 737.87 million a year ago. Revenue was TWD 761.46 million compared to TWD 737.87 million a year ago. Net income was TWD 46.79 million compared to TWD 50.42 million a year ago. Basic earnings per share from continuing operations was TWD 0.82 compared to TWD 0.88 a year ago. Diluted earnings per share from continuing operations was TWD 0.82 compared to TWD 0.88 a year ago.